CD4 and metastatic malignant neoplasm in the lymph nodes: Based on logistic regression, we generated a nomogram that integrated GARP, GARP+CD4+ T cell, and other clinicopathological features, including tumor size, lymph node metastasis, distant metastasis, TNM stage, tumor differentiation to predict the probability of 1-year, 3-year, and 5-year overall survival for GC patients with the GSE84437 and the experimental cohort (Figures 5A, , C).